Russian drug manufacturers are reorienting from Ukraine to Donbass
Russian pharmaceutical manufacturers will lose from 1,5 to 1,7 billion rubles in 2017 if Ukraine, as reported by the Ministry of Health of Ukraine, imposes sanctions on Russian medicines, the analytical company RNC Pharma calculated at the request of RBC. Subscribe to PolitNavigator news on Telegram, Facebook, Odnoklassniki or Vkontakte Analysts indicated that the volume of drug supplies to Ukraine excluding the DPR and LPR in 2016 amounted to 2,1 billion rubles, and the Ukrainian market accounts for 7,7%...